![Ka-Ching: How global drug makers are riding on luck in their pursuit of blockbuster drugs, vaccines](https://img.etimg.com/thumb/msid-107697591,width-1015,height-761,imgsize-107944,resizemode-8/prime/pharma-and-healthcare/ka-ching-how-global-drug-makers-are-riding-on-luck-in-their-pursuit-of-blockbuster-drugs-vaccines.jpg)
Synopsis
The recent successes of leading pharmaceutical products show that drug companies have been plain lucky to hit the jackpot. While long-term strategies continue to be important, drug makers have often struck gold with pipeline compounds that they had once simply dumped.
Does serendipity help pharmaceutical companies rake in megabucks? Well, if one were to trace the genesis of some key blockbuster drugs of recent years, it becomes evident that luck has swung the fortunes of global pharma giants even in the era of data-backed research, regenerative AI, and machine learning. Though the knowledge of genetics and cell biology has leapfrogged over time and companies with cutting-edge research enjoy a lead when it
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Uh-oh! This is an exclusive story available for selected readers only.
Worry not. You’re just a step away.
Why ?
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
Clean experience with
Minimal AdsComment & Engage with ET Prime community Exclusive invites to Virtual Events with Industry Leaders A trusted team of Journalists & Analysts who can best filter signal from noise Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-